Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer.

已完结 10 由 jing 发布于 2025/8/26 15:54:15

DOI:10.1007/s10147-025-02760-y
作者：Ryutaro Onaga,?Tomohiro Enokida,?Shingo Sakashita,?Nobukazu Tanaka,?Yuta Hoshi,?Takuma Kishida,?Ryo Kuboki,?Takao Fujisawa,?Susumu Okano,?Hiroshi Nishino,?Makoto Ito,?Genichiro Ishii,?Shumpei Ishikawa
文献类型：期刊论文
补充材料：只需要正文

Springer

Abstract：Background: BRAF V600E mutation is a significant therapeutic target for thyroid cancer, including anaplastic thyroid cancer (ATC). Although targeted therapy for this mutation requires genomi

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SpringerA Systematic Literature Review on Personalised Learning in the Higher Education Context